Lexaria Corp CSE:LXX OTC:LXRP

More
1 year 11 months ago #118493 by Peter
Peter replied the topic: Lexaria Corp CSE:LXX OTC:LXRP
I am still holding. sitting on nice profit so content to let it play out

Please Log in or Create an account to join the conversation.

More
1 year 11 months ago #118486 by GoldnBoy
GoldnBoy replied the topic: Lexaria Corp CSE:LXX OTC:LXRP
I am still in long and strong, it has held up well as the sector has corrected

2017-07-18 09:13 ET - News Release

Mr. Alex Blanchard reports

LEXARIA BIOSCIENCE AWARDED AUSTRALIAN PATENT FOR CANNABINOID INFUSED EDIBLES

The Australian Patent Office has granted patent No. 2015274698 which protects Lexaria Bioscience Corp.'s method of improving absorption, speed of onset and taste of cannabinoid active agents in edible products. The term of the patent is 20 years from June 10, 2015.

The issuance of this patent guards Lexaria's intellectual property for the edible delivery of all non-psychoactive cannabinoids, including those that are incidental but contributory to cannabis oils used in psychoactive cannabinoid edibles. A wide variety of foods and beverage formats are covered, including but not limited to: tea, coffee, cocoa powder, fresh foods and meats, dairy products, pastas, breads, seeds, nuts, spices, herbs, candies, flavourings, and more.

One of Lexaria's core strategies is to develop and solidify key IP (intellectual property) applicable to different economic sectors within specific market jurisdictions domestically and abroad, as a prerequisite to developing revenue-producing business operations linked thereto.

"We are very pleased to have received this patent which effectively covers all cannabis oil extract formulated edibles utilizing our technology in Australia," stated Lexaria chief executive officer Chris Bunka. "This patent award allows us to confidently enter the recently legalized Australian cannabis marketplace where we will seek additional licensing and product distribution partnering opportunities."

A patent granting the same set of claims was granted in the United States in October, 2016. Lexaria expects additional progress on its extensive patent portfolio through the balance of 2017 and in 2018.

Please Log in or Create an account to join the conversation.

More
2 years 1 month ago #118087 by Mark
Mark replied the topic: Lexaria Corp CSE:LXX OTC:LXRP
Been quiet here, sounds like very good news as company well cashed up. From last weeks news release

"Lexaria's balance sheet is now the strongest it has ever been," commented Chris Bunka, chief executive officer. "We have raised over $3-million (U.S.) in the past six months, which fully funds the company's business plans until 2019. We are now focused on developing our patent portfolio and continuing our work with prospective licensees and resellers."

Please Log in or Create an account to join the conversation.

  • alexgreat
  • alexgreat's Avatar
  • Away
  • Platinum Member
  • Platinum Member
More
2 years 1 month ago #118031 by alexgreat
alexgreat replied the topic: Lexaria Corp CSE:LXX OTC:LXRP
This could be huge if it works

2017-05-10 09:31 ET - News Release

Mr. Chris Bunka reports

LEXARIA ANNOUNCES RESEARCH ON NONSTEROIDAL ANTI-INFLAMMATORY DRUGS

Lexaria Bioscience Corp. plans to begin research and formulation development (R&D) on non-steroidal anti-inflammatory drugs (NSAIDs) utilizing its patented technology and as provisioned within its previously announced 2017 and 2018 R&D program.

Lexaria will conduct in vitro absorption studies utilizing the company's technology to examine improvements in absorption across human intestinal tissue, which is expected to be followed by in vivo (animal) studies to confirm the company's hypothesis regarding first-pass liver metabolism. The company postulates that its technology may enable oral delivery of NSAIDs without encountering first-pass liver metabolism, which has the potential to greatly reduce corresponding liver damage.

Pain relief drugs comprise mostly NSAIDs and opioids, and represented a $36.6-billion market in 2014. Long-term use or overuse of NSAIDs has been associated with chronic liver conditions that can be debilitating and even cause death.

Common generic forms of NSAIDS are products such as aspirin, ibuprofen, naproxen, diclofenac and others. Acetaminophen is sometimes included within this list. More effective absorption of NSAIDS may also lead to more effective pain killing properties, thus allowing for fewer opioid medication prescriptions. Prescription-based opioid medications are responsible for nearly 18,000 deaths annually in the United States.

Lexaria has a total of 18 patents pending -- including the delivery of NSAIDs -- and patent applications filed in more than 40 countries worldwide.

Please Log in or Create an account to join the conversation.

More
2 years 1 month ago #118003 by Gambler
Gambler replied the topic: Lexaria Corp CSE:LXX OTC:LXRP
Nicotine could end up bigger for LXX than Canabis

Thursday May 4 2017 - News Release

Mr. Chris Bunka reports

LEXARIA ANNOUNCES R&D ON NICOTINE

Lexaria Bioscience Corp. plans to commence nicotine absorption research beginning in the summer of 2017, within its previously announced research and development budget that is fully funded.

Lexaria is developing leading technology for the more effective gastro-intestinal delivery of cannabinoids, vitamins, pain relievers, and other active molecules. Many active molecules are currently delivered in formats that are not conducive to human health and there is no better example than cigarette smoking that delivers nicotine.

Lexaria believes there are large and untapped markets available including for more efficient and healthy delivery of nicotine through edible products. In fact, nicotine administration in controlled studies has been found to be a potentially healthful molecule including in some studies shown to potentially be related to a decrease in incidence of Parkinson's disease. (University of Washington, Journal of Neuroscience)

Despite the fact that cigarette smoking is the leading cause of preventable death in the world (Euromonitor International and the World Health Organization) the global cigarette industry was worth $699 billion in 2015 with over 5.5 trillion cigarettes sold to over 1 billion customers. Current trends show that tobacco use will cause more than 8 million annual deaths by 2030. (Centers for Disease Control and Prevention)

In 2017 Lexaria will perform its first ever nicotine absorption studies utilizing human intestinal tissue in an in vitro environment, to determine whether Lexaria's technology assists in greater absorption of nicotine across the intestinal wall.

Positive 2017 results from Lexaria's in vitro nicotine testing would support the concept that an edible product containing nicotine could form an alternative to cigarettes as a nicotine delivery system. If successful, in vivo follow-up testing would be required to determine whether the Lexaria technology also aids in intestinal tolerance.

Lexaria currently has a total of 18 patents pending -- including for applying its technology to nicotine delivery -- and patent applications filed in more than 40 countries around the world.

Please Log in or Create an account to join the conversation.

More
2 years 2 months ago #117914 by Gambler
Gambler replied the topic: Lexaria Corp CSE:LXX OTC:LXRP
Great news as they managed to close on a financing even when the stock weakened. US$0.42 is around C$0.55


Lexaria Bioscience Corp. (OTCQB: LXRP) (CSE: LXX) (the "Company" or "Lexaria") is pleased to announce that it has completed its previously announced brokered private placement of 4,104,280 units of the Company ("Units") at a price per Unit of US$0.42 (the "Offering Price"), for total gross proceeds of US$1,723,798 (the "Offering").

Please Log in or Create an account to join the conversation.

  • alexgreat
  • alexgreat's Avatar
  • Away
  • Platinum Member
  • Platinum Member
More
2 years 2 months ago #117894 by alexgreat
alexgreat replied the topic: Lexaria Corp CSE:LXX OTC:LXRP
The stock looks like a real good buy here

Please Log in or Create an account to join the conversation.

More
2 years 3 months ago #117876 by DearJohn
DearJohn replied the topic: Lexaria Corp CSE:LXX OTC:LXRP
Agree more great news, did you look into Philip Morris going with a smokeless cigarette?

""A few important steps are needed to make this common-sense approach a reality for millions of smokers. First, you need to invent less harmful alternatives to cigarettes. Second, these alternatives should be appealing to smokers: they should deliver a taste and sensory experience that leads smokers, who would otherwise continue to smoke, to switch. We can achieve a significant public-health benefit only when a large number of these smokers switch from cigarettes to better products.""

www.pmi.com/science-and-innovation/commo...ch-for-public-health

Please Log in or Create an account to join the conversation.

More
2 years 3 months ago #117872 by lynnsa10
lynnsa10 replied the topic: Lexaria Corp CSE:LXX OTC:LXRP
Been quiet here, some more good news

I think they have the goods, just have to get sales rolling


2017-03-22 09:32 ET - News Release

Mr. Chris Bunka reports

LEXARIA INTRODUCES TURBOCBD BRAND OF HIGH ABSORPTION FULL SPECTRUM HEMP OIL CAPSULES

Lexaria Bioscience Corp. has introduced the TurboCBD brand of technologically enhanced, high-absorption full-spectrum hemp oil capsules. Lexaria's TurboCBD capsules are specially formulated with the finest American ginseng and ginkgo biloba for support of enhanced focus and memory, and reduced stress and fatigue.

TurboCBD capsules utilize Lexaria's patented absorption technology and are triple tested for purity. They are made without the use of organic solvents and leave no hemp oil aftertaste. They are vegan, gluten free, sugar free, nut free and made in the United States. They will soon be offered for sale through California medical cannabis dispensaries and other select locations as the perfect complement to any cannabis regimen.

Lexaria's TurboCBD capsules are designed to work with the physiology of the human gastrointestinal system where minute quantities of long-chain fatty acids like sunflower oil, combined in each serving of TurboCBD capsules, are thoroughly and quickly absorbed into the circulatory system for maximum effectiveness. In vitro and human focus study testing has shown increases in cannabidiol (CBD) absorption using Lexaria's technology by as much as five to times more than conventional preparations. Those studies also demonstrated rapid onset of action in as little as 15 minutes.

Lexaria intends to showcase its TurboCBD capsules at the upcoming 2017 World Medical Marijuana Business Conference & Expo in Pittsburgh on April 21 and April 22, which is expected to attract over 8,000 cannabis professionals, including 1,200 physicians interested in the sector.

Lexaria is further researching other capsule formulations utilizing its patented absorption technology, each of which would be uniquely formulated to address specific market demands. Testing with Lexaria's technology has shown equally good improvements in enhancing absorption and rapidity of action when working with tetrahydrocannabinol (THC) as shown for CBD, and Lexaria continues to develop and seek opportunities to lever its technology for THC product applications through licensees in the U.S., Canada and internationally.

Please Log in or Create an account to join the conversation.

More
2 years 3 months ago #117768 by GoldnBoy
GoldnBoy replied the topic: Lexaria Corp CSE:LXX OTC:LXRP
More good news today


Monday February 27 2017 - News Release

Mr. Chris Bunka reports

LEXARIA RECEIVES NOTICE OF ITS FIRST PATENT TO BE GRANTED IN AUSTRALIA FOR CANNABINOID INFUSED EDIBLES

Lexaria Bioscience Corp. has received a notice of acceptance from the Australian Patent Office that Lexaria's Australian patent application 2015274698 has been accepted with a patent issuance date expected in June, 2017. This establishes Lexaria's first successful acceptance for patent issuance outside of the United States, in what the company expects will be a series of successful international patent awards.

The notice of acceptance covers Lexaria's patent application entitled "Food and beverage compositions infused with lipophilic active agents and methods of use thereof," which has been accepted with the same set of claims previously issued in U.S. patent No. 9,474,725 specific to non-psychoactive cannabinoids.

Lexaria is very pleased with the rapid advancement of its patent claims by the Australian Patent Office and notes Australia's recent federal legislative success in opening the medical cannabis market. Like Canada, the medical cannabis market in Australia is federally legal.

"Lexaria's technology is needed not just in the U.S. but throughout the global cannabis sector, which is why we have patent applications in place in 42 countries around the world," said Chris Bunka, chief executive officer. "Our international applications offer the safety of unparalleled diversification to our supporters that even individual national market leaders cannot offer."

The accepted patent application includes a series of Lexaria's method claims for combining non-psychoactive cannabinoid lipophilic active agents together with a bioavailability and taste-enhancing oil by way of dehydration or lyophilization, and doing so in contact with a food product substrate material. Lexaria still has a number of additional patent applications undergoing review by the U.S. Patent and Trademark Office and patent application continuations planned in order to further broaden its expected set of compositional and method patent claims regarding the technology for application with other molecules such as psychoactive cannabinoids, vitamins, non-steroidal anti-inflammatory drugs and nicotine.

The company continues to thank its many supporters who have contributed to its intellectual property success.

Please Log in or Create an account to join the conversation.

More
2 years 4 months ago #117707 by DearJohn
DearJohn replied the topic: Lexaria Corp CSE:LXX OTC:LXRP
Stock hanging in there nice, looks to be making a good base for next run

Please Log in or Create an account to join the conversation.

More
2 years 4 months ago #117663 by Gambler
Gambler replied the topic: Lexaria Corp CSE:LXX OTC:LXRP
Great news, it seems every news release gets better, surprised this stock is still so cheap when you look at the others in the sector

Please Log in or Create an account to join the conversation.

Time to create page: 0.322 seconds
© 2019 Playstocks.net. All Rights Reserved. Designed By JoomShaper